XML 26 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 1,158 $ 1,192
Accounts receivable, net of allowance for credit losses of $28 and $15 as of December 31, 2020 and 2019, respectively 1,520 1,063
Inventories 223 123
Prepaid expenses and other current assets 157 112
Total current assets 3,058 2,490
Property, plant and equipment, net 1,627 1,453
Operating lease right-of-use assets 604 518
Goodwill 6,873 6,619
Intangible assets, net 1,167 1,121
Investments in equity method investees 521 482
Other assets 176 160
Total assets 14,026 12,843
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,633 1,041
Less: Current portion of long-term debt 2 804
Current portion of long-term operating lease liabilities 141 145
Total current liabilities 1,776 1,990
Long-term debt 4,013 3,966
Long-term operating lease liabilities 499 413
Other liabilities 847 711
Commitments and contingencies
Redeemable noncontrolling interest 82 76
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2020 and 2019; 217 shares issued as of both December 31, 2020 and 2019 2 2
Additional paid-in capital 2,841 2,722
Retained earnings 9,303 8,174
Accumulated other comprehensive (loss) income (21) (39)
Treasury stock, at cost; 84 shares as of both December 31, 2020 and 2019 (5,366) (5,218)
Total Quest Diagnostics stockholders' equity 6,759 5,641
Noncontrolling interests 50 46
Total stockholders' equity 6,809 5,687
Total liabilities and stockholders' equity $ 14,026 $ 12,843
Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]    
Treasury stock, shares 84 84